They reported that endothelial dysfunction occurs as a result of the SARS-CoV-2 spike protein interacting with an angiotensin-converting enzyme (ACE-2) and that ACE-2 expression increases in COVID-19 [38, 39]. This evidence concerns the gene ACE2 and COVID-19.